| 标题 |
Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet HIV 作者:Dirk Schürmann; Deanne Jackson Rudd; Saijuan Zhang; Inge De Lepeleire; Martine Robberechts; et al 出版日期:2020-03-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)